Addus HomeCare Logo
US0067391062
A0YBKM
ADUS

Addus HomeCare

Previsioni

Il prezzo obiettivo medio degli analisti è 117,34 € (+4,77%). La mediana è 123,49 € (+10,26%).

Acquista
  15
Mantieni
  2
Vendi
  1

Discussioni nella community

Non ci sono ancora discussioni su questo asset.

Avvia discussione

  • Addus HomeCare announces acquisition of AccentCare personal-care unit and growth plan

    Addus HomeCare will acquire AccentCare’s personal care services unit for $275 million; the deal has a revenue run rate of $280 million and is expected to close in Q1 2027. Management views the acquisition as a key growth step, expects gradual margin improvements in the AccentCare business within 12–18 months, and plans phased system integrations through end‑2027/early 2028. Consolidated personal-care utilization improves company‑wide (84–85%), and Addus targets same‑store revenue growth of 3–5%; after closing the company expects a pro‑forma leverage ratio just above 1.0x and remains open to further acquisitions. » Altro su de.investing.com


  • Addus HomeCare says license moratorium won't hinder personal care growth or M&A plans

    Addus HomeCare said the federal moratorium on certain home health licenses does not apply to personal care services (PCS), which have driven its recent acquisitions, and therefore should not slow revenue growth. Management reported improving PCS census trends and higher caregiver fill rates after deploying a caregiver app in key states like Illinois and Texas. The company highlighted acquisition opportunities—including expansion in Indiana—saying deal valuations have declined and its balance sheet and credit line allow rapid execution. Addus also continues clinical and hospice integrations while converting PCS to a unified EMR to better identify referrals and care transitions. » Altro su finance.yahoo.com


  • Addus HomeCare falls to 52-week low at $90.80

    Shares of Addus HomeCare hit a 52-week low of $90.80 and have fallen about 16% over the past year. Key metrics: P/E 17, PEG 0.78 and a market capitalization of roughly $1.68 billion, suggesting potential undervaluation. The company reported Q1 2026 EPS of $1.62 (expected $1.55) on revenue of $363.6 million, which missed the consensus but rose 7.7% year over year. In response to the revenue miss, a financial services firm cut its price target from $150 to $142 and kept its rating at "Market Outperform." » Altro su de.investing.com


  • Addus reports Q1 2026 revenue up 7.7% and strengthens cash flow while expanding into Indiana

    Addus delivered Q1 2026 revenue of $363.6 million, a 7.7% increase year-over-year, with adjusted EPS of $1.62 and adjusted EBITDA of $44.5 million. Operating cash flow rose to $52.4 million, cash on hand was about $103 million and bank debt fell to $94.3 million, giving the company capacity for M&A. The firm closed the HomeCourt Home Care personal care acquisition in Indiana and signed a second Indiana deal pending approvals, continuing a strategy to add scale and geographic density. Personal care same-store revenue rose 6.5% and hospice same-store revenue rose 7.7%, while Addus emphasized caregiver-app rollouts to boost hours served and operational efficiency. » Altro su finance.yahoo.com


  • Addus HomeCare shares fall to 52-week low at $91.10

    Addus HomeCare shares hit a 52-week low of $91.10 and are down 5.58% year to date. Key metrics show a P/E ratio of 17.56 and a PEG of 0.74; InvestingPro rates the stock as undervalued and the RSI signals oversold conditions. The company remains profitable with revenue growth of 23% over the past twelve months. Several analysts reiterated buy or overweight ratings with price targets between $135 and $150, though a few analysts slightly lowered their targets. » Altro su de.investing.com

Dati finanziari

Nell'ultimo trimestre, Addus HomeCare ha registrato ricavi pari a 342,31 Mln € e un utile netto di 25,24 Mln €

(EUR) settembre 2026
YoY
Ricavi 342,31 Mln 10,88%
Utile lordo 109,82 Mln 10,43%
Utile netto 25,24 Mln 29,66%
EBITDA 38,81 Mln 19,51%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
2,05 Mld €
Numero di azioni
18,63 Mln
Massimo/minimo a 52 settimane
119,92 € - 80,15 €
Dividendi No
Beta
0,75
Rapporto P/E
20,14
Rapporto PEG
0,73
Rapporto P/B
1,90
Rapporto P/S
1,50

Profilo aziendale

Addus HomeCare Corporation, insieme alle sue controllate, fornisce servizi di assistenza personale a persone anziane, cronicamente malate, disabili e a individui a rischio di ospedalizzazione o di ricovero in istituto negli Stati Uniti. L'azienda opera attraverso tre segmenti: Personal Care, Hospice e Home Health. Il segmento Personal Care fornisce assistenza non medica nelle attività quotidiane della vita. Questo segmento offre servizi che includono l'assistenza nel bagno, nella cura personale, nell'igiene orale, nell'alimentazione e nel vestirsi, promemoria per l'assunzione di farmaci, pianificazione e preparazione dei pasti, servizi di pulizia domestica e servizi di trasporto. Il segmento Hospice fornisce assistenza infermieristica palliativa, servizi di assistenza sociale, consulenza spirituale, assistenza domestica e consulenza in caso di lutto per persone in fase terminale, nonché servizi correlati per i loro familiari. Il segmento Home Health offre assistenza infermieristica qualificata e fisioterapia, terapia occupazionale e logopedia per le persone che necessitano di assistenza durante una malattia o dopo un ricovero ospedaliero. I clienti pagatori dell'azienda includono agenzie governative federali, statali e locali; organizzazioni di managed care; assicuratori commerciali; e privati. Al 31 dicembre 2021, l'azienda serviva i consumatori attraverso 206 uffici situati in 22 stati. Addus HomeCare Corporation è stata fondata nel 1979 e ha sede a Frisco, Texas.

Nome
Addus HomeCare
CEO
R. Dirk Allison
Sede centrale Frisco, tx
Stati Uniti
Sito web
Settore
Sanità
Industria
Fornitori e servizi sanitari
Quotazione in borsa
28/10/2009
Dipendenti 50.659

Simboli di borsa

Borsa Simbolo
NASDAQ
ADUS
Frankfurt
A41.F
Düsseldorf
A41.DU
SIX
A41.SW
München
A41.MU
🍪

Parqet  usa i cookie. Scopri di più